vs
Nutex Health, Inc.（NUTX）与GIBRALTAR INDUSTRIES, INC.（ROCK）财务数据对比。点击上方公司名可切换其他公司
GIBRALTAR INDUSTRIES, INC.的季度营收约是Nutex Health, Inc.的1.5倍（$225.0M vs $151.7M），GIBRALTAR INDUSTRIES, INC.同比增速更快（24.9% vs -41.1%），Nutex Health, Inc.自由现金流更多（$69.0M vs $26.2M），过去两年Nutex Health, Inc.的营收复合增速更高（50.0% vs -12.3%）
Nutex Health是一家总部位于美国得克萨斯州休斯敦的营利性医疗企业，核心业务为运营各类医疗机构，是美国本土医疗领域的专业运营机构，致力于为当地市场提供相关医疗服务与场地运营支持。
直布罗陀工业公司是专业建筑、基础设施及可再生能源产品制造商与分销商，主营通风系统、屋面配件、太阳能安装支架、园林景观产品等，主要服务北美地区住宅、商业建筑及清洁能源市场，专注提供创新可持续的客户解决方案。
NUTX vs ROCK — 直观对比
营收规模更大
ROCK
是对方的1.5倍
$151.7M
营收增速更快
ROCK
高出66.1%
-41.1%
自由现金流更多
NUTX
多$42.8M
$26.2M
两年增速更快
NUTX
近两年复合增速
-12.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $151.7M | $225.0M |
| 净利润 | $11.8M | — |
| 毛利率 | 30.4% | 25.3% |
| 营业利润率 | 20.4% | 7.9% |
| 净利率 | 7.8% | — |
| 营收同比 | -41.1% | 24.9% |
| 净利润同比 | -80.8% | — |
| 每股收益（稀释后） | $2.34 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NUTXROCK
| Q4 25 | $151.7M | $225.0M | ||
| Q3 25 | $267.8M | $310.9M | ||
| Q2 25 | $244.0M | $309.5M | ||
| Q1 25 | $211.8M | $290.0M | ||
| Q4 24 | $257.6M | $180.1M | ||
| Q3 24 | $78.8M | $277.1M | ||
| Q2 24 | $76.1M | $273.6M | ||
| Q1 24 | $67.5M | $292.5M |
净利润NUTXROCK
| Q4 25 | $11.8M | — | ||
| Q3 25 | $55.4M | $-89.1M | ||
| Q2 25 | $-17.7M | $26.0M | ||
| Q1 25 | $21.2M | $21.1M | ||
| Q4 24 | $61.6M | — | ||
| Q3 24 | $-8.8M | $34.0M | ||
| Q2 24 | $-364.0K | $32.2M | ||
| Q1 24 | $-364.0K | $24.9M |
毛利率NUTXROCK
| Q4 25 | 30.4% | 25.3% | ||
| Q3 25 | 57.8% | 26.6% | ||
| Q2 25 | 51.2% | 28.4% | ||
| Q1 25 | 55.9% | 26.8% | ||
| Q4 24 | 55.0% | 29.0% | ||
| Q3 24 | 27.8% | 29.4% | ||
| Q2 24 | 29.7% | 30.5% | ||
| Q1 24 | 15.1% | 28.9% |
营业利润率NUTXROCK
| Q4 25 | 20.4% | 7.9% | ||
| Q3 25 | 48.7% | 12.8% | ||
| Q2 25 | 13.8% | 12.8% | ||
| Q1 25 | 38.1% | 8.8% | ||
| Q4 24 | 44.4% | 13.3% | ||
| Q3 24 | 12.3% | 15.6% | ||
| Q2 24 | 7.0% | 14.9% | ||
| Q1 24 | 2.1% | 10.8% |
净利率NUTXROCK
| Q4 25 | 7.8% | — | ||
| Q3 25 | 20.7% | -28.6% | ||
| Q2 25 | -7.3% | 8.4% | ||
| Q1 25 | 10.0% | 7.3% | ||
| Q4 24 | 23.9% | — | ||
| Q3 24 | -11.2% | 12.3% | ||
| Q2 24 | -0.5% | 11.8% | ||
| Q1 24 | -0.5% | 8.5% |
每股收益（稀释后）NUTXROCK
| Q4 25 | $2.34 | — | ||
| Q3 25 | $7.76 | $-2.98 | ||
| Q2 25 | $-2.95 | $0.87 | ||
| Q1 25 | $3.33 | — | ||
| Q4 24 | $11.56 | — | ||
| Q3 24 | $-1.72 | $1.11 | ||
| Q2 24 | $-0.07 | $1.05 | ||
| Q1 24 | $-0.08 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $185.6M | $115.7M |
| 总债务越低越好 | — | $0 |
| 股东权益账面价值 | $329.4M | $950.4M |
| 总资产 | $918.5M | $1.4B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资NUTXROCK
| Q4 25 | $185.6M | $115.7M | ||
| Q3 25 | $166.0M | $89.4M | ||
| Q2 25 | $96.7M | $43.3M | ||
| Q1 25 | $84.7M | $25.1M | ||
| Q4 24 | $40.6M | $269.5M | ||
| Q3 24 | $46.9M | $228.9M | ||
| Q2 24 | $40.8M | $179.1M | ||
| Q1 24 | $30.0M | $146.7M |
总债务NUTXROCK
| Q4 25 | — | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
股东权益NUTXROCK
| Q4 25 | $329.4M | $950.4M | ||
| Q3 25 | $317.2M | $951.8M | ||
| Q2 25 | $235.3M | $1.0B | ||
| Q1 25 | $176.9M | $1.0B | ||
| Q4 24 | $132.4M | $1.0B | ||
| Q3 24 | $60.4M | $1.0B | ||
| Q2 24 | $62.7M | $975.7M | ||
| Q1 24 | $63.0M | $940.2M |
总资产NUTXROCK
| Q4 25 | $918.5M | $1.4B | ||
| Q3 25 | $964.5M | $1.4B | ||
| Q2 25 | $841.0M | $1.5B | ||
| Q1 25 | $761.9M | $1.4B | ||
| Q4 24 | $655.3M | $1.4B | ||
| Q3 24 | $438.5M | $1.4B | ||
| Q2 24 | $422.4M | $1.4B | ||
| Q1 24 | $404.3M | $1.3B |
负债/权益比NUTXROCK
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $70.4M | $35.5M |
| 自由现金流经营现金流 - 资本支出 | $69.0M | $26.2M |
| 自由现金流率自由现金流/营收 | 45.5% | 11.7% |
| 资本支出强度资本支出/营收 | 0.9% | 4.1% |
| 现金转化率经营现金流/净利润 | 5.95× | — |
| 过去12个月自由现金流最近4个季度 | $245.6M | $120.6M |
8季度趋势，按日历期对齐
经营现金流NUTXROCK
| Q4 25 | $70.4M | $35.5M | ||
| Q3 25 | $99.5M | $73.0M | ||
| Q2 25 | $27.3M | $44.9M | ||
| Q1 25 | $51.0M | $13.7M | ||
| Q4 24 | $54.0K | $19.9M | ||
| Q3 24 | $6.8M | $64.7M | ||
| Q2 24 | $13.3M | $36.5M | ||
| Q1 24 | $3.1M | $53.2M |
自由现金流NUTXROCK
| Q4 25 | $69.0M | $26.2M | ||
| Q3 25 | $99.2M | $64.8M | ||
| Q2 25 | $26.5M | $27.3M | ||
| Q1 25 | $50.9M | $2.3M | ||
| Q4 24 | $-341.0K | $14.1M | ||
| Q3 24 | $6.2M | $60.5M | ||
| Q2 24 | $12.7M | $33.5M | ||
| Q1 24 | $2.3M | $48.8M |
自由现金流率NUTXROCK
| Q4 25 | 45.5% | 11.7% | ||
| Q3 25 | 37.0% | 20.8% | ||
| Q2 25 | 10.9% | 8.8% | ||
| Q1 25 | 24.0% | 0.8% | ||
| Q4 24 | -0.1% | 7.8% | ||
| Q3 24 | 7.8% | 21.8% | ||
| Q2 24 | 16.7% | 12.2% | ||
| Q1 24 | 3.4% | 16.7% |
资本支出强度NUTXROCK
| Q4 25 | 0.9% | 4.1% | ||
| Q3 25 | 0.1% | 2.6% | ||
| Q2 25 | 0.3% | 5.7% | ||
| Q1 25 | 0.0% | 3.9% | ||
| Q4 24 | 0.2% | 3.3% | ||
| Q3 24 | 0.8% | 1.5% | ||
| Q2 24 | 0.7% | 1.1% | ||
| Q1 24 | 1.1% | 1.5% |
现金转化率NUTXROCK
| Q4 25 | 5.95× | — | ||
| Q3 25 | 1.80× | — | ||
| Q2 25 | — | 1.73× | ||
| Q1 25 | 2.40× | 0.65× | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 2.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
